157 related articles for article (PubMed ID: 10548634)
1. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy.
Kawaguchi K; Fujii S; Konishi I; Iwai T; Nanbu Y; Nonogaki H; Ishikawa Y; Mori T
Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):309-15. PubMed ID: 1949613
[TBL] [Abstract][Full Text] [Related]
3. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
[TBL] [Abstract][Full Text] [Related]
5. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.
Viville B; Charnock-Jones DS; Sharkey AM; Wetzka B; Smith SK
Hum Reprod; 1997 Apr; 12(4):815-22. PubMed ID: 9159448
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
9. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium.
Sadan O; van Iddekinge B; van Gelderen CJ; Savage N; Becker PJ; van der Walt LA; Robinson M
Ann Clin Biochem; 1987 May; 24 ( Pt 3)():263-7. PubMed ID: 3606010
[TBL] [Abstract][Full Text] [Related]
11. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
Harrison-Woolrych ML; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1994 May; 78(5):1179-84. PubMed ID: 8175976
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle.
Chrapusta S; Sieinski W; Konopka B; Szamborski J; Paszko Z
Eur J Gynaecol Oncol; 1990; 11(5):381-7. PubMed ID: 2097155
[TBL] [Abstract][Full Text] [Related]
13. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
Harrison-Woolrych ML; Sharkey AM; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1853-8. PubMed ID: 7775632
[TBL] [Abstract][Full Text] [Related]
14. [The characteristics of the content of estrogen and progesterone receptors in uterine myoma and the myometrium].
Kozachenko AV; Landekhovskiĭ IuD; Kondrikov NI; Kushlinskiĭ NE; Gershteĭn ES
Akush Ginekol (Mosk); 1995; (6):34-6. PubMed ID: 8779352
[No Abstract] [Full Text] [Related]
15. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
[TBL] [Abstract][Full Text] [Related]
16. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen and progesterone receptor status and PgR/ER ratios in normal and myomatous human myometrium.
Potgieter HC; Magagane F; Bester MJ
East Afr Med J; 1995 Aug; 72(8):510-4. PubMed ID: 7588146
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens.
Ichimura T; Kawamura N; Ito F; Shibata S; Minakuchi K; Tsujimura A; Umesaki N; Ogita S
Fertil Steril; 1998 Nov; 70(5):967-71. PubMed ID: 9806586
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
Shimomura Y; Matsuo H; Samoto T; Maruo T
J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
[TBL] [Abstract][Full Text] [Related]
20. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
